BIO-Key International Inc
NASDAQ:BKYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BIO-Key International Inc
NASDAQ:BKYI
|
US |
|
T
|
thyssenkrupp nucera AG & Co KgaA
F:NCH2
|
DE |
|
P
|
Pfizer Inc
XETRA:PFE
|
US |
|
ASML Holding NV
AEX:ASML
|
NL |
|
Sectra AB
STO:SECT B
|
SE |
|
Industrivarden AB
OTC:IDDTF
|
SE |
|
Korn Ferry
NYSE:KFY
|
US |
Wall St Price Targets
BKYI Price Targets Summary
BIO-Key International Inc
According to Wall Street analysts, the average 1-year price target for BKYI is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BKYI's stock price target?
Price Target
20.4
USD
According to Wall Street analysts, the average 1-year price target for BKYI is 20.4 USD with a low forecast of 20.2 USD and a high forecast of 21 USD.
What is the Revenue forecast for BIO-Key International Inc?
Projected CAGR
21%
Over the last 12 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 21%.
What is the Gross Profit forecast for BIO-Key International Inc?
Projected CAGR
21%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 21%.
